2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$403.67-$3.60 (-0.88%)
Price as of Oct 02, 2026 3:22 PM EDT- $220.2BMarket Cap
- 40.74%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$403.67-$3.60 (-0.88%)
AMGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $407.27 | ||
Change | -$14.24 (-3.38%) | ||
Open | $421.72 | ||
High | $422.80 | ||
Low | $407.13 | ||
Previous Close | $421.51 | ||
Volume | 2,501,031 | ||
30-Day Average Volume | 3,165,423 | ||
1-Week Change | 0.30% | ||
1-Month Change | -7.04% | ||
1-Year Change | 40.74% | ||
3-Year Change | 65.79% | ||
5-Year Change | 122.43% | ||
Fundamentals | |||
Shares Outstanding | 540.6M | ||
Total Assets | $95.6B | ||
Market Cap | $220.2B | ||
Enterprise Value | $263.5B | ||
Period: QTR TTM FY | |||
Revenue | $9.5B | ||
Net Income | $2.4B | ||
Free Cash Flow | $3.5B | ||
EBIT | $3.4B | ||
EBITDA | $4.6B | ||
Net Working Capital | $9.5B | ||
EPS | $4.37 | ||
Enterprise Value/EBITDA | 58 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 19 | ||
P/E | 93 | ||
PEG | 3 | ||
Price/Free Cash Flow | 63 | ||
Price/Operating Cash Flow | 55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.48% | ||
Trailing Annual Dividend Yield | 2.44% | ||
Ex-Dividend Date | 08/21/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield